Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dezocine on the effective dose of sufentanil to suppress cardiovascular reaction during anesthesia induction and endotracheal intubation
ChiCTR2000039261Phase 4Recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil, sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoints: Blood pressure and Heart rate. Started Oct 2020; status: recruiting.
02
Drugs
sufentanil
Beyond the preview
Go deeper on ChiCTR2000039261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039261.